Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER). Am Heart J. 2014 Oct; 168(4):588-96.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Dose-Response Relationship, Drug
Double-Blind Method
Electrocardiography
Female
Follow-Up Studies
Humans
Lactones
Male
Middle Aged
Myocardial Revascularization
Peripheral Arterial Disease
Pyridines
Receptors, Thrombin
Retrospective Studies
Treatment Outcome

authors with profiles

Robert Harrington